Quick Answer
PROCEPT BioRobotics Corp reported Total Revenue of $308.05 million for fiscal year 2025.
PROCEPT BioRobotics Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $308.05M +37.2% |
$224.50M +64.8% |
$136.19M +81.6% |
$75.01M +117.6% |
$34.47M +346.7% |
$7.72M |
| Revenue (ASC 606) | $308.05M +37.2% |
$224.50M +64.8% |
$136.19M +81.6% |
$75.01M +117.6% |
$34.47M +346.7% |
$7.72M |
| Net Income | -$95.57M -4.5% |
-$91.41M +13.7% |
-$105.90M -21.5% |
-$87.15M -45.6% |
-$59.85M -12.9% |
-$53.02M |
| Diluted EPS | -$1.72 +1.7% |
-$1.75 +21.9% |
-$2.24 -14.3% |
-$1.96 +46.0% |
-$3.63 +74.9% |
-$14.47 |
| Total Assets | $508.08M -4.9% |
$534.02M +31.9% |
$404.72M +30.8% |
$309.33M -8.2% |
$337.02M +167.5% |
$125.97M |
| Cash and Equivalents | $286.50M -14.1% |
$333.73M +29.7% |
$257.22M +15.9% |
$221.86M -27.1% |
$304.32M +203.9% |
$100.13M |
| Long-Term Debt | $51.62M +0.3% |
$51.47M +0.3% |
$51.34M +0.2% |
$51.21M +2.4% |
$50.00M +12.6% |
$44.41M |
| Stockholders Equity | $365.87M -9.0% |
$402.22M +43.3% |
$280.75M +42.5% |
$197.07M -26.2% |
$267.09M +246.0% |
-$182.89M -27.2% |
| R&D Expense | $71.28M +14.4% |
$62.30M +28.6% |
$48.45M +67.2% |
$28.98M +52.6% |
$18.99M +16.7% |
$16.27M |
| Operating Income | -$103.86M -7.5% |
-$96.61M +11.5% |
-$109.17M -35.2% |
-$80.72M -49.0% |
-$54.16M -13.3% |
-$47.80M |
| Gross Profit | $196.23M +43.1% |
$137.10M +93.0% |
$71.05M +91.6% |
$37.09M +133.8% |
$15.87M +1364.1% |
-$1.25M |
| Shares Outstanding | 56.32M +2.9% |
54.72M +7.8% |
50.77M | — | 43.68M +826.7% |
4.71M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $83.33M | +42.8% | +5.2% |
| Revenue (ASC 606) | September 30, 2025 | $83.33M | +42.8% | +5.2% |
| Net Income | September 30, 2025 | -$21.41M | -2.1% | -9.4% |
| Diluted EPS | September 30, 2025 | -$0.38 | +5.0% | -8.6% |
| Total Assets | September 30, 2025 | $511.54M | +36.7% | -0.3% |
| Cash and Equivalents | September 30, 2025 | $294.28M | +49.6% | -2.8% |
| Long-Term Debt | September 30, 2025 | $51.57M | +0.2% | +0.1% |
| Stockholders Equity | September 30, 2025 | $380.28M | +57.6% | -1.4% |
| R&D Expense | September 30, 2025 | $18.19M | +9.3% | +3.1% |
| Operating Income | September 30, 2025 | -$23.19M | -3.4% | -4.5% |
| Gross Profit | September 30, 2025 | $54.01M | +46.3% | +4.4% |
| Shares Outstanding | September 30, 2025 | 55.87M | +7.1% | +0.5% |
- PROCEPT BioRobotics Corp reported Total Revenue of $308.05 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed an increase of +37.2% in Total Revenue compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Revenue (ASC 606) of $308.05 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed an increase of +37.2% in Revenue (ASC 606) compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Net Income of -$95.57 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed a decrease of -4.5% in Net Income compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Diluted EPS of $1.72 per share (loss) for fiscal year 2025.
- PROCEPT BioRobotics Corp showed an increase of +1.7% in Diluted EPS compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Total Assets of $508.08 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed a decrease of -4.9% in Total Assets compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Cash and Equivalents of $286.50 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed a decrease of -14.1% in Cash and Equivalents compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Long-Term Debt of $51.62 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed an increase of +0.3% in Long-Term Debt compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Stockholders Equity of $365.87 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed a decrease of -9.0% in Stockholders Equity compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported R&D Expense of $71.28 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed an increase of +14.4% in R&D Expense compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Operating Income of -$103.86 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed a decrease of -7.5% in Operating Income compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Gross Profit of $196.23 million for fiscal year 2025.
- PROCEPT BioRobotics Corp showed an increase of +43.1% in Gross Profit compared to the prior fiscal year.
- PROCEPT BioRobotics Corp reported Shares Outstanding of 56.32 million shares for fiscal year 2025.
- PROCEPT BioRobotics Corp showed an increase of +2.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: